We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
BioTime acquires Geron's stem cell program.
- Authors
Brower, Vicki
- Abstract
The article focuses on the acquisition of stem cell program of the California-based Geron Corp. by California-based BioTime Inc. It mentions that both the companies made agreement on the proper working of human embryonic stem cell (hESC) program and also promised to contribute intellectual property rights and cash money for the development of program. It further highlights that BioTime will provide certain rights to patents and also pay royalties to Geron on sales of commercialized products.
- Subjects
CALIFORNIA; GERON Corp.; BIOTIME Inc.; INTELLECTUAL property; HUMAN embryonic stem cells; ROYALTIES (Copyright)
- Publication
Nature Biotechnology, 2013, Vol 31, Issue 2, p94
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0213-94a